Contact for pricing🇩🇪
Munich-based deepcOS platform that lets health systems connect, run and monitor AI applications from many vendors in one place.
Lunit AI features and pricing (October 2026)
Medical AI from Seoul for cancer detection in mammography and chest X-ray, plus biomarker analysis in pathology.
Contact for pricing
Pricing: Contact for pricing
No prices on the website; inquiries through the sales team, as of September 2026.
What is Lunit?
Lunit is a South Korean medical AI company for cancer screening and precision oncology. Its INSIGHT products support radiologists reading chest X-rays and mammograms, and its SCOPE suite analyzes pathology slides for research and drug development.
Lunit was founded in 2013 in Seoul, is listed on KOSDAQ and has acquired Volpara, a breast imaging software company. The vendor states it operates in more than 70 countries and at more than 10,000 customer sites. Radiology products cover chest X-ray, 2D mammography and tomosynthesis, while the SCOPE suite covers tumor microenvironment analysis, immunohistochemistry quantification and genotype prediction for oncology research and biopharma partners.
Lunit AI features and use cases
- Reads chest X-raysINSIGHT CXR checks chest radiographs for eleven major thoracic abnormalities, including nodules, pneumothorax, consolidation, pleural effusion and acute fractures, and supports tuberculosis screening. Radiologists get a second look and a marked image before they report.
- Scores mammogramsINSIGHT MMG analyzes 2D mammograms, assigns a malignancy likelihood score and highlights areas of interest. The vendor positions it for single and double reading in high-volume screening, which can reduce callbacks.
- Guides tomosynthesis readingINSIGHT DBT points radiologists to key slices in 3D breast tomosynthesis stacks. This shortens the search through many slices and reduces reading fatigue. The final assessment of each case stays with the reading radiologist.
- Quantifies pathology slidesThe SCOPE suite analyzes digitized tissue slides for tumor microenvironment, immunohistochemistry scores and genotype prediction. Oncology researchers and drug developers get consistent quantitative biomarker readouts. The suite is aimed at research and biopharma partners rather than routine reporting.
What sets Lunit apart
- INSIGHT MMG shows FDA clearance, CE marking and Health Canada approval on its product page.
- INSIGHT CXR can run on premises or in the Azure cloud, with a local DICOM gateway that anonymizes data before transfer.
- Covers both radiology screening and pathology biomarker analysis for biopharma partners.
Where Lunit is strongest
South Korea Available internationally
Lunit is headquartered in Seoul and listed on South Korea's KOSDAQ exchange.
Questions to ask before you buy Lunit
Images are health data under Art. 9 GDPR and HIPAA. For INSIGHT CXR, decide between on-premises and cloud deployment; in the cloud option a local gateway anonymizes data before it reaches Azure. Lunit notes that products are not available in all countries, so confirm the regulatory status for your market and product. Radiologists remain responsible for the final report.
Lunit reviews
No reviews yet. Be the first to share how your team uses it.
Every review shows its verification level. We read each one before it goes live. How we check reviews
Questions about Lunit
Can Lunit run without sending images to the cloud?
Yes. INSIGHT CXR supports on-premises deployment where data is analyzed locally. In the cloud option a local DICOM gateway anonymizes data before transfer to Azure.
Is Lunit INSIGHT MMG cleared in the US and Europe?
The INSIGHT MMG product page shows FDA clearance, CE marking and Health Canada approval. Regulatory details for other Lunit products are listed on its regulatory information page.
Does Lunit also serve pharma and research?
Yes. The SCOPE suite, including SCOPE IO, the SCOPE IHC suite and SCOPE GP, analyzes pathology slides for tumor microenvironment, immunohistochemistry and genotype prediction.
Lunit update historyno updates yet
No changes recorded for Lunit yet.
Changes the vendor made and confirmed user reports, each checked against the vendor's own pages. We review every tool monthly.
Alternatives to Lunit
Tools in the same category (Medical imaging) with the most overlapping markets.
Contact for pricing🇮🇳🇺🇸🇬🇧
Indian medical imaging AI for chest X-rays, head CT and lung nodules, with FDA clearances and CE marking for several products.
Contact for pricing🇺🇸
US platform for AI-supported care coordination that flags suspected stroke and brain bleeds on CT and alerts care teams.
Contact for pricing🇮🇱🇺🇸
Clinical AI platform aiOS that analyzes imaging in the background, prioritizes urgent findings and alerts care teams.